InvestorsHub Logo
icon url

tredenwater2

11/14/22 1:36 PM

#383198 RE: ckent #383196

Very good point CKent and yet another of so many positives.

I really dont understand how the man sleeps at night knowing what he knows, remarkable.
icon url

growingpain

11/14/22 1:42 PM

#383200 RE: ckent #383196

Yeah, good pumping from Missling!
icon url

peeved

11/14/22 1:47 PM

#383202 RE: ckent #383196

The reason for this may be

that the 50 mg did statistical significant but 30 did not

I don't think we need both dosing to be successful. I would imagine if 1 is p < 0.025 then it is success
icon url

frrol

11/14/22 2:56 PM

#383214 RE: ckent #383196

That would be terrific outcomes for the primary endpoints in a controlled 500+ n AD trial. Let's see.
icon url

Red_Right_Hand

11/14/22 4:50 PM

#383236 RE: ckent #383196

It seems to me that the risk (to CM personally, and to the company) of making a public and recorded statement like this, while at the same time being aware that the ALZ trial (already PR'd to report TLD on 12/1) has missed its endpoints, is far too great for most anyone, but especially CM, to make. I think this bodes very well for the outcomes to be reported on 12/1.
icon url

attilathehunt

11/14/22 7:21 PM

#383254 RE: ckent #383196

"Placebo, thirty, fifty." "

Maybe he is telegraphing that our share price is the placebo and followed by a 30B MC fro AD and then 50B MC with PDD and Rett.

Sounds good to me!!! :)